Ophthalmic 1 drop in affected eye(s) TID; topical Mirvaso 0.33% gel applied to face daily
preparations
String
0.1%, 0.15%, 0.2% ophthalmic solutions; 0.33% topical gel; combinations with timolol (Combigan) and brinzolamide (Simbrinza)
fda_max
String
TID per eye
pill_id
Text
routes
List of String, delimiter: ,
Topical ophthalmic • topical skin
onset
String
IOP lowering at 1 hour; max at 2-3 hours
duration
String
8-12 hours
halflife
String
~3 hours'"`UNIQ--ref-000010D1-QINU`"'
bioavailability
String
Topical; clinically meaningful systemic absorption can produce systemic α2 effects (somnolence, hypotension), especially in children'"`UNIQ--ref-000010D2-QINU`"'
pregnancy
String
Limited data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup>
